CAPTRUST Financial Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LXRX
AG
SL
CAPTRUST Financial Advisors's LXRX Position: Q3 2026 in Review
CAPTRUST Financial Advisors reduced its Lexicon Pharmaceuticals (LXRX) stake by 0.42% in Q3 2026, selling an estimated $145 and leaving 15,256 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3305.
CAPTRUST Financial Advisors first reported a position in LXRX in Q1 2021 and has held it in 18 quarters since. The position peaked at $113K in Q1 2023. 156 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.
- CAPTRUST Financial Advisors held 15,256 shares of Lexicon Pharmaceuticals worth $28.6K as of Q3 2026.
- CAPTRUST Financial Advisors sold 65 Lexicon Pharmaceuticals shares in Q3 2026, an estimated $145.
- Lexicon Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3305 holding.
- CAPTRUST Financial Advisors first reported a position in Lexicon Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
- CAPTRUST Financial Advisors's Lexicon Pharmaceuticals position peaked at $113K in Q1 2023.
- 156 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.